Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending January 27, 2023

Drug Industry TRx: -0.5% w/w; +7.1% y/y

Vascepa
TRx 57,799; -0.8% (-465) w/w; -23.5% y/y
NRx 27,009; -1.1% (-293) w/w; -25.5% y/y
Ref 30,789; -0.6% (-172) w/w; -21.7% y/y

Fake Vascepa
TRx 44,735; -6.0% (-2,852) w/w; As % of total V: 43.6%
NRx 22,311; -6.0% (-1,419) w/w; As % of total V: 45.2%
Ref 22,424; -6.0% (-1,433) w/w; As % of total V: 42.1%

Fake Vascepa by Manufacturer
Hikma - TRx 16,958; -24 w/w; Generic share 37.9%; Total V share 16.5%
Reddy - TRx 19,024; -2,680 w/w; Generic share 42.5%; Total V share 18.6%
Apotex - TRx 8,347; -143 w/w; Generic share 18.7%; Total V share 8.1%
Teva - TRx 407; -4 w/w; Generic share 0.9%; Total V share 0.4%

Vascepa + Fake Vascepa
TRx 102,534; -3.1% (-3,316) w/w; +0.6% y/y
NRx 49,321; -3.4% (-1,711) w/w; -5.3% y/y
Ref 53,213; -2.9% (-1,605) w/w; +6.6% y/y

Lovaza (Fake & Brand)
TRx 63,476; -2.2% (-1,429) w/w; +1.2% y/y
NRx 32,164; -0.8% (-268) w/w; -3.7% y/y
Ref 31,312; -3.6% (-1,161) w/w; +6.8% y/y